Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Hepatitis C

  Free Subscription

Articles published in Scand J Gastroenterol

Retrieve available abstracts of 6 articles:
HTML format

Single Articles

    March 2023
  1. CASTEDAL M, Schult A, Kotopouli MI, Bottai M, et al
    Alcohol as a risk factor for mortality in liver transplant patients in Sweden.
    Scand J Gastroenterol. 2023;58:269-275.
    PubMed     Abstract available

    September 2022
  2. LEIVA RA, Bergersen BM, Finbraten AK, Sandvei PK, et al
    High real-world effectiveness of 12-week elbasvir/grazoprevir without resistance testing in the treatment of patients with HCV genotype 1a infection in Norway.
    Scand J Gastroenterol. 2022 Sep 5:1-5. doi: 10.1080/00365521.2022.2118555.
    PubMed     Abstract available

    June 2021
  3. WALDENSTROM J, Hellstrand K, Westin J, Nilsson S, et al
    Presence of interferon-lambda 4, male gender, absent/mild steatosis and low viral load augment antibody levels to hepatitis C virus.
    Scand J Gastroenterol. 2021 Jun 2:1-6. doi: 10.1080/00365521.2021.1922750.
    PubMed     Abstract available

    May 2021
  4. WALDENSTROM J, Kaberg M, Alanko Blome M, Widell A, et al
    Absence of interferon-lambda 4 enhances spontaneous clearance of acute hepatitis C virus genotypes 1-3 infection.
    Scand J Gastroenterol. 2021 May 25:1-7. doi: 10.1080/00365521.2021.1925956.
    PubMed     Abstract available

  5. PIECHA F, Ganssler JM, Ozga AK, Wehmeyer MH, et al
    Evolution of liver stiffness and post-treatment surveillance by liver elastography for HCV patients in the DAA era.
    Scand J Gastroenterol. 2021 May 19:1-9. doi: 10.1080/00365521.2021.1915374.
    PubMed     Abstract available

    March 2021
  6. STOY S, Terczynska-Dyla E, Veidal SS, Rigbolt K, et al
    Interferon lambda 4 genotype and pathway in alcoholic hepatitis.
    Scand J Gastroenterol. 2021;56:304-311.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.